Trial Profile
A phase I study of Ivermectin (mdc-STM) for treatment of Malaria
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Ivermectin (Primary)
- Indications Malaria
- Focus Adverse reactions
- 26 Jun 2023 According to a MedinCell media release, the company expect to initiate this trial in 2024 with the support of Unitaid.
- 24 Jun 2021 New trial record
- 14 Jun 2021 According to a MedinCell media release, the company expect to initiate this trial in 2023.